• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • SGSC Global Bootcamp 2021
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
  • Investment Opportunities
    • SGSC Demo Day
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • register
  • login
No Result
View All Result
No Result
View All Result
Home Health & Bio

Orum Therapeutics’ new medicines can treat cancer and assist in genetic diseases

KoreaTechDesk Writer by KoreaTechDesk Writer
December 24, 2018
in Health & Bio
4
Orum Therapeutics’ new medicines can treat cancer and assist in genetic diseases
8
SHARES
154
VIEWS
Share on FacebookShare on Twitter

Mutations affecting the RAS gene isoforms are the most common phenomenon in several cancer types. Scientists have struggled to find a drug that can target the right cells and combat the disease. South Korean biotech startup Orum Therapeutics has developed a way to block the activity of RAS in tumour cells affecting ​cancer treatment.

Next Generation Antibody Therapy

Orum is creating the next generation of antibody therapies. The biotech company and its cell-penetrating antibody platform can transform antibodies to effectively target undruggable cytosolic targets, such as KRAS. This provides new opportunities to treat severe genetic diseases and cancer. Orum’s antibody platform can target specific cell types and does not require chemical conjugation.

Orum published data in 2017 presenting that systemic administration of the antibody developed by them had selective anti-tumour activity, targeting mutant RAS, in early-stage animal models for human colorectal cancer and fibrosarcoma.  The company in a statement said that the treatment had “measurable antitumor activity” in mice with tumours containing a RAS mutation.

The CEO and Co-founder of Orum, Sung Joo Lee said, “As an anti-cancer therapy, our cell penetrating antibodies are easy to produce, allow for systemic administration that is well tolerated, and have desirable pharmacological properties.” He added, “We believe this could be a very important first-in-class therapeutic for hard-to-treat pancreatic, colon and non-small cell lung cancers.”

Expanding to International shores

In 2016, Orum Therapeutics was selected to participate in the Tech Incubator Program for Startup (TIPS), a program that supports promising startups. In 2017, the startup raised $8 million as their Series A investment to support their work on the monoclonal antibody. The Daejeon based biotech firm had investments from InterVest, KB Investment/Solidus Investment, and LB Investment. The company recently expanded.

Earlier in 2018, Orum Therapeutics moved to a bigger office and lab location in Daejeon. The company expanded their reach to Boston, USA. Sung Joo Lee said, “We look forward to joining the strong biotech ecosystem in Massachusetts and working with talented individuals who are passionate about bringing new medicines to patients with life-threatening illnesses.”

What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: Antibody TherapyCANCERGenetic diseaseHealthcareRASTIPS
Previous Post

Standigm: Applying Artificial Intelligence to Improve Drug Discovery Research

Next Post

BiLabs: Revolutionary Technology in Cardiopulmonary Medicine

Next Post
BiLabs: Revolutionary Technology in Cardiopulmonary Medicine

BiLabs: Revolutionary Technology in Cardiopulmonary Medicine

0 0 votes
Article Rating
Subscribe
Login
Notify of
Please login to comment
4 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
trackback
แทงบอลออนไลน์
2 months ago

… [Trackback]

[…] Read More to that Topic: koreatechdesk.com/orum-therapeutics-new-medicines-can-treat-cancer-and-assist-in-genetic-diseases/ […]

0
trackback
kspods.com
2 months ago

… [Trackback]

[…] Find More on that Topic: koreatechdesk.com/orum-therapeutics-new-medicines-can-treat-cancer-and-assist-in-genetic-diseases/ […]

0
trackback
cvvshop lv
2 months ago

… [Trackback]

[…] Find More Info here to that Topic: koreatechdesk.com/orum-therapeutics-new-medicines-can-treat-cancer-and-assist-in-genetic-diseases/ […]

0
trackback
iptv kaufen
14 hours ago

… [Trackback]

[…] Read More Information here to that Topic: koreatechdesk.com/orum-therapeutics-new-medicines-can-treat-cancer-and-assist-in-genetic-diseases/ […]

0
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • Top Korean startup event COMEUP 2022 accepting applications for COMEUP Stars program

    0 shares
    Share 0 Tweet 0
  • Top Korean Dating apps that can help you make new connections in South Korea

    12 shares
    Share 12 Tweet 0
  • Korean Ministry selects 60 promising startups for the ‘Baby Unicorn’ project 2022

    0 shares
    Share 0 Tweet 0
  • 10 K-Dramas to watch for some ‘money matters’

    0 shares
    Share 0 Tweet 0
  • Top 3 Websites where you watch Korean drama & movies

    12 shares
    Share 12 Tweet 0
  • Medical AI startup Lunit makes KOSDAQ debut with 28.7% surge in stock price

    0 shares
    Share 0 Tweet 0
  • Korean startup DeepBrain AI launches service to ‘digitally immortalize’ deceased loved ones

    0 shares
    Share 0 Tweet 0
  • Korean financial super app Toss operator Viva Republica attracts $228 million investment

    0 shares
    Share 0 Tweet 0
  • Korean Webtoon companies that are giving the audience addictive content

    15 shares
    Share 0 Tweet 0
  • Three Restaurant Apps to try out for a fine dining experience in South Korea  

    9 shares
    Share 9 Tweet 0
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2022 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • MSS
    • NIPA
    • SBA
    • SFL
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login

Copyright © 2022 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

Posting....
wpDiscuz
4
0
Would love your thoughts, please comment.x
()
x
| Reply

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.